"Eye" Education for Parents and Myopia Control in Children
Launched by BEIJING TONGREN HOSPITAL · Oct 21, 2024
Trial Information
Current as of June 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Eye Education for Parents and Myopia Control in Children," is designed to study how teaching parents about eye health can help control the development of nearsightedness, or myopia, in children. The trial will involve children aged 5 to 17 who have certain vision requirements, such as good corrected vision and specific levels of myopia and astigmatism. Participants will be randomly placed into two groups: one group will receive regular eye health education for their parents over six months, while the other group will not receive this information.
Parents of children in the education group can expect to learn more about how to manage their child's eye health and myopia progression through meetings at the start of the trial and again at one month, three months, and six months. The trial will track various eye health measures and emotional well-being to see if parental education makes a difference in managing myopia. It's important to note that children with certain eye conditions or those who have had specific surgeries will not be eligible to participate. This study aims to provide valuable insights into how parental education can support children's eye health.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria
- • 1. Children aged 5-17;
- • 2. Removing flexible lenses for at least 1 week, flexible astigmatism and hard lenses for at least 3 weeks, orthokeratology lenses for at least 3 months;
- • 3. Best corrected visual acuity of either eye were all ≥ 1.0;
- • 4. The range of myopia in either eye was -15 D ≤ SE ≤ +2.0 D;
- • 5. Astigmatism of either eye less than -5.0 D;
- • 6. Anisometropia ≤ -1.5 D;
- • 7. There was no active ocular inflammatory diseases; no obvious corneal cloud or macula, anormal corneal topography, and no tendency of keratoconus.
- • 8. Intraocular pressure of either eye is of 10 to 21 mmHg;
- • 9. On the basis of full understanding, children and their guardians sign the informed consent;
- Exclusion Criteria:
- • 1. Amblyopia: best corrected visual acuity (BCVA) of either eye less than 1.0 for children over 6 years old;
- • 2. Active ocular inflammatory diseases, such as uveitis and other inflammatory diseases;
- • 3. Secondary myopia, genetic disease or connective tissue- related myopia;
- • 4. Moderate or severe ptosis;
- • 5. Congenital cataract, glaucoma;
- • 6. Other fundus diseases other than myopic related fundus lesions;
- • 7. Intraocular or refractive surgery history;
- • 8. The refractive medium is turbid, and it is impossible to take a clear fundus image; (9)Unable to cooperate with fundus image shooting and other examination;
- • (10)Do not receive cycloplegia or have contraindications; (11)Poor overall condition, unable to follow up for a long time; (12)The subject refuses to participate in the research; (13)Other cases in which the researcher judges that it is not suitable for participation in the study.
About Beijing Tongren Hospital
Beijing Tongren Hospital, affiliated with Capital Medical University, is a leading medical institution in China known for its comprehensive clinical services and research initiatives. With a strong focus on ophthalmology and a commitment to advancing healthcare through innovative clinical trials, the hospital leverages its expertise in various specialties to contribute to medical knowledge and improve patient outcomes. The institution is dedicated to adhering to the highest ethical standards and regulatory requirements, ensuring the integrity and reliability of its research endeavors. Through collaboration with national and international partners, Beijing Tongren Hospital aims to enhance the quality of care and foster advancements in medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported